The Effect of Intracoronary Reinfusion of Bone Marrow-derived Mononuclear Cells(BM-MNC) on All Cause Mortality in Acute Myocardial Infarction

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
This is a multinational, multicentre, randomised open-label, controlled, parallel-group phase III study. Its aim is to demonstrate that a single intracoronary infusion of autologous bone marrow-derived mononuclear cells is safe and reduces all-cause mortality in patients with reduced left ventricular ejection fraction(\
Epistemonikos ID: 89e7cf00be897f5bc49a54e2dd2b108c68ec0656
First added on: May 10, 2024